Arrive AI (ARAI) disclosed Tuesday the issuance of a new US patent for an artificial intelligence-based platform, expanding its capabilities by enabling temperature-controlled heating and cooling for precision handling.
Shares nearly doubled as intraday trading volume catapulted to over 36.2 million from a daily average of about 354,000.
Evogene (EVGN) reported Tuesday the completion of its generative AI foundation model for small molecule design, developed in collaboration with Google Cloud, part of Alphabet (GOOG, GOOGL).
Shares soared 95% as intraday trading volume soared to over 93.7 million from a daily average of roughly 374,000.
Gelteq (GELS) reported Tuesday the expansion of its US commercial strategy via an exclusive logistics and distribution agreement with Healthy Extracts, a firm focused on producing plant-based health supplements.
Shares jumped 60% as intraday trading volume advanced to more than 72.4 million from a daily average of about 1.5 million.
Price: 12.53, Change: +6.24, Percent Change: +99.05
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。